A mutually exclusive pattern of B7-H4 with PD-L1 expression has been demonstrated in some types of cancer, such as breast cancers, lung cancer and glioma [40–42], suggesting that some types of cancers might be preferentially undergoing B7-related immune evasion pathway. The gene discussed is VTCN1; the disease is central nervous system cancer.